Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma

BACKGROUND: High dose melphalan (HDMEL) is considered the standard conditioning regimen for autologous stem cell transplantation (ASCT) in multiple myeloma (MM) patients. Recent studies showed superiority of busulfan plus melphalan (BUMEL) compared to HDMEL as a conditioning regimen. We compared the...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Songyi, Shin, Dong-Yeop, Hong, Junshik, Kim, Inho, Koh, Youngil, Byun, Ja Min, Yoon, Sung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Advances in Multiple Myeloma (MM)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111524/
https://www.ncbi.nlm.nih.gov/pubmed/33995990
http://dx.doi.org/10.1177/20406207211012985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111524/
https://www.ncbi.nlm.nih.gov/pubmed/33995990
http://dx.doi.org/10.1177/20406207211012985

Ejemplares similares